↓ Skip to main content

Cochrane Database of Systematic Reviews

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

Overview of attention for article published in Cochrane database of systematic reviews, October 2003
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
14 news outlets
blogs
1 blog
twitter
1 tweeter
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
216 Dimensions

Readers on

mendeley
131 Mendeley
Title
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
Published in
Cochrane database of systematic reviews, October 2003
DOI 10.1002/14651858.cd004000
Pubmed ID
Authors

Richmal M Oates-Whitehead, J Harry Baumer, Linda Haines, Samantha Love, Ian K Maconochie, Amit Gupta, Kevin Roman, Jaspal S Dua, Ichiko Flynn

Abstract

Kawasaki disease is the most common cause of acquired heart disease in children in developed countries. The coronary arteries supplying the heart can be damaged in Kawasaki disease. The principal advantage of timely diagnosis is the potential to prevent this complication with early treatment. Intravenous immunoglobulin (IVIG) is widely used for this purpose.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Brazil 1 <1%
Unknown 129 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 16%
Other 20 15%
Student > Master 17 13%
Student > Bachelor 12 9%
Student > Ph. D. Student 10 8%
Other 26 20%
Unknown 25 19%
Readers by discipline Count As %
Medicine and Dentistry 69 53%
Nursing and Health Professions 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Agricultural and Biological Sciences 2 2%
Immunology and Microbiology 2 2%
Other 10 8%
Unknown 38 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 112. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2022.
All research outputs
#318,680
of 23,033,713 outputs
Outputs from Cochrane database of systematic reviews
#559
of 12,353 outputs
Outputs of similar age
#228
of 52,239 outputs
Outputs of similar age from Cochrane database of systematic reviews
#4
of 35 outputs
Altmetric has tracked 23,033,713 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,353 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.4. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 52,239 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.